HCAT financial statements and SEC filings
HCAT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $311.14M | -$160.85M | -$177.97M | 10-K |
| 2024-12-31 | $306.58M | -$69.81M | -$69.50M | 10-K |
| 2023-12-31 | $295.94M | -$126.90M | -$118.15M | 10-K |
| 2022-12-31 | $276.24M | -$140.00M | -$137.40M | 10-K |
| 2021-12-31 | $241.93M | -$143.65M | -$153.21M | 10-K |
| 2020-12-31 | $188.84M | -$96.12M | -$115.02M | 10-K |
HCAT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $502.64M | $256.86M | $245.78M | 10-Q |
| 2024-12-31 | $858.93M | $493.72M | $365.21M | 10-K |
| 2023-12-31 | $701.81M | $334.89M | $366.92M | 10-K |
| 2022-12-31 | $752.29M | $327.28M | $425.01M | 10-K |
| 2021-12-31 | $832.10M | $310.00M | $522.10M | 10-K |
| 2020-12-31 | $577.74M | $301.64M | $276.10M | 10-K |
HCAT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $731.00K | -$968.00K | -$235.78M | 10-K |
| 2024-12-31 | $14.56M | -$1.62M | $151.75M | 10-K |
| 2023-12-31 | -$33.08M | -$1.24M | $2.73M | 10-K |
| 2022-12-31 | -$35.27M | -$2.17M | -$2.61M | 10-K |
| 2021-12-31 | -$23.12M | -$10.45M | $264.08M | 10-K |
| 2020-12-31 | -$26.15M | -$7.78M | $182.61M | 10-K |